Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-1 infection

Blood

Volumn 89, Issue 5, 1997, Pages 1642-1653

  López Guerrero, José Antonio ^b   Rayet, Béatrice ^b   Tuynder, Marcel ^b   Rommelaere, Jean ^a   Dinsart, Christiane ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL KILLING; CELL PROLIFERATION; CELL SELECTION; CELL SPECIFICITY; COLONY FORMATION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; ONCOGENE; PARVOVIRUS; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; VIRUS REPLICATION;

EID: 1842292133     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1642.1642_1642_1653     Document Type: Article

References (64)

1. Tattersall PA, Ward DC: The Parvoviruses: An introduction, in Ward DC, Tattersall P (eds): Replication of Mammalian Parvoviruses. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory, 1978, p 3
2. Anderson MJ: Parvoviruses as agents of human disease. Prog Med Virol 34:55, 1987
3. Siegl G: Biology and pathogenicity of autonomous parvoviruses, in Berns KI (ed): The Parvoviruses. New York, NY, Plenum, 1984, p 297
4. Berns KI: Parvovirus replication. Microbiol Rev 54:316, 1990
5. Carter BJ: Variant and defective interfering parvoviruses, in Berns KI (ed): The Parvoviruses, New York, NY, Plenum, 1984, p 209
6. Cotmore SF, Tattersall P: The autonomously replicating parvoviruses of vertebrates. Adv Virus Res 33:91, 1987
7. Tijssen P: Introduction: Parvoviruses, in Tijssen P (ed): Handbook of Parvoviruses, vol 1, Boca Raton, FL, CRC, 1990, p 3
8. Faisst S, Faisst SR, Dupressoir T, Plaza S, Pujol A, Jauniaux JC, Rhode SL, Rommelaere J: Isolation of a fully infectious variant of parvovirus H-1 supplanting the standard strain in human cells. J Virol 69:4538, 1995
9. Rommelaere J, Cornelis JJ: Antineoplasic activity of parvoviruses. J Virol Methods 33:233, 1991
10. Mousset S, Rommelaere J: Minute virus of mice inhibits cell transformation by simian virus 40. Nature 300:537, 1982
11. Cornelis JJ, Becquart P, Duponchel N, Salomé N, Avalosse BL, Namba M, Rommelaere J: Transformation of human fibroblasts by ionizing radiation, a chemical carcinogen, or SV40 correlates with an increase in susceptibility to the autonomous parvoviruses H-1 virus and minute virus of mice. J Virol 62:1679,1988
12. Chen YQ, Tuynder MC, Cornelis JJ, Boukamp P, Fusenig NE, Rommelaere J: Sensitization of human keratinocytes to killing by parvovirus H-1 takes place during their malignant transformation but does not require them to be tumorigenic. Carcinogenesis 10: 163, 1989
13. Cornelis JJ, Chen YQ, Spruyt N, Duponchel N, Cptmore SF, Tattersall P, Rommelaere J: Susceptibility of human cells to killing by the parvoviruses H-1 and minute virus of mice correlates with viral transcription. J Virol 64:2537, 1990
14. Mousset S, Quadrhiri Y, Caillet-Fauquet P, Rommelaere J: The cytotoxicity of the autonomous parvovirus minute virus of mice nonstructural proteins in FR3T3 rat cells depends on oncogene expression. J Virol 68:6446, 1994
15. Telerman A, Tuynder M, Dupressoir T, Robaye B, Sigaux F, Shaulian E, Oren M, Rommelaere J, Amson R: A model for tumor suppression using H-1 parvovirus. Proc Natl Acad Sci USA 90:8702, 1993
16. Sundström C, Nilsson K: Establishment and characterization of a human histiocytic lymphoma cell line (U937). Int J Cancer 17:565, 1976
17. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9:3389, 1994
18. Lübbert M, Miller CW, Crawford L, Koeffler HP: p53 in chronic myelogenous leukemia. Study of mechanisms of differential expression. J Exp Med 167:873, 1988
19. Einat M, Resnitzky D, Kimchi A: Close link between reduction of c-myc expression by interferon and G0/G1 arrest. Nature 313:597, 1985
20. Rovera G, O'Brien TG, Diamond L: Induction of differentiation of human promyelocytic leukemia cells by tumour promoters. Science 204:868, 1979
21. Rovera G, Ferraro D, Pagliardi GL, Vartikar J, Pessano S, Bottera L, Abraham S, Lebman D: Induction of differentiation of human myeloid leukemias by phorbol esters: Phenotypic changes and mode of action. Ann NY Acad Sci 397:211, 1982
22. Larsson LG, Ivhed I, Gidlund M, Pettersson U, Vennström B, Nilsson K: Phorbol ester-induced terminal differentiation is inhibited in human U937 monoblastic cells expressing v-myc oncogene. Proc Natl Acad Sci USA 85:2638, 1988
23. Morgenbesser SD, Schreiber-Agus N, Bidder M, Mahon KA, Overbeek PA, Horner J, DePinho RA: Contrasting roles for c-Myc and L-Myc in the regulation of cellular growth and differentiation in vivo. EMBO J 14:743, 1995
24. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
25. Cavanaugh AH, Hempel WM, Taylor LJ, Rogalsky V, Todorov G, Rothblum LI: Activity of RNA polymerase I transcription factor UBF blocked by Rb gene product. Nature 374:117, 1995
26. Rustgi AK, Dyson N, Bernards R: Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352:541, 1991
27. Lasky SR, Posner MR, Iwata K, Santos-Moore A, Yen A, Samuel V, Clark J, Maizel AL: Characterization of a vitamin D3-resistant human chronic myelogenous leukemia cell line. Blood 84:4583, 1994
28. Hinds PW, Weinberg RA: Tumour suppressor genes. Curr Opin Genet Dev 4:135, 1994
29. Montenarh M: Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene 7:1673, 1992
30. Shein HM, Enders JF: Multiplication and cytopathogenicity of simian vacuolating virus 40 in cultures of human tissue. Proc Soc Exp Biol Med 109:495, 1962
31. Chen YQ, de Foresta F, Hertoghs J, Avalosse BL, Cornelis JJ, Rommelaere J: Selective killing of simian virus 40-transformed human fibroblasts by parvovirus H-1. Cancer Res 46:3574, 1986
32. Hirt B: Selective extraction of polyoma DNA from infected mouse cells culture. J Mol Biol 26:365, 1967
33. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
34. López-Guerrero JA, López-Bote JP, Ortiz MA, Gupta RS, Páez E, Bernabeu C: Modulation of adjuvant arthritis in Lewis rats by recombinant vaccinia virus expressing the human 60-kilodalton heat shock protein. Infect Immun 61:4525, 1993
35. López-Guerrero JA, Cabañas C, Bernabeu C, Fresno M, Alonso MA: Poliovirus infection interferes with the phorbol ester-induced differentiation of the monocytic U937 cell line. Virus Res 14:65, 1989
36. Rothein R, Dustin ML, Martin SD, Springer TA: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137:245, 1986
37. Rook GAW, Steele J, Umar S, Dockrell HM: A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by g-interferon. J Immunol Methods 82:161, 1985
38. Green LC, Wagner DA, Glogowsky J, Skipper PL, Wishnok JS, Tannenbaum JS: Analysis of nitrate, nitrite and (15N) nitrate in biological fluids. Anal Biochem 126:131, 1982
39. Brandenburger A, Legendre D, Avalosse B, Rommelaere J: NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp. Virology 174:576, 1990
40. Yarden A, Shure-Gottlieb H, Chebath J, Revel M, Kimchi A: Autogenous production of interferon-beta switches on HLA genes during differentiation of histiocytic lymphoma U937 cells. EMBO J 3:969, 1984
41. Mitchell RL, Zokas L, Schreiber RD, Verma IM: Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation. Cell 40:209, 1985
42. Sherman ML, Stone RM, Datta R, Bernstein SH, Kufe DW: Transcriptional and post-transcriptional regulation of c-jun expression during monocytic differentiation of human myeloid leukemic cells. J Biol Chem 265:3320, 1990
43. Cole MD: The myc oncogene: Its role in transformation and differentiation. Annu Rev Genet 20:361, 1986
44. Richon VM, Ramsay RG, Rifkind RA, Marks P: Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erytnroleukemia cell differentiation. Oncogene 4:165, 1989
45. Hass R, Bartels H, Topley N, Hadam M, Köhler L, Goppelt-Strübe M, Resch K: TPA-induced differentiation and adhesion of U937 cells: Changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur J Cell Biol 48:282, 1989
46. Harris P, Ralph P: Human leukemic models of myelomonocytic development: A review of the HL-60 and U937 cell lines. J Leukoc Biol 37:407, 1985
47. Schmidt HHHW, Walter U: NO at work. Cell 78:919, 1994
48. Stamler JS: Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell 78:931, 1994
49. Lander HM, Sehajpal P, Levine DM, Novogrodsky A: Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J Immunol 150:1509, 1993
50. Babior MB: The respiratory burst of phagocytes. J Clin Invest 73:599, 1984
51. Magrinat G, Mason SN, Shami PJ, Weinberg JB: Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80:1880, 1992
52. Harris N, Buller RML, Karupiah G: Gamma interferon-induced, nitric oxide-mediated inhibition of vaccinia virus replication. J Virol 69:910, 1995
53. Karupiah G, Xie QW, Buller RML, Nathan C, Duarte C, MacMicking JD: Inhibition of viral replication by interferon-g-induced nitric oxide synthase. Science 261:1445, 1993
54. Croen KD: Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91:2446, 1993
55. Bi Z, Reiss CS: Inhibition of vesicular stomatitis virus infection by nitric oxide. J Virol 69:2208, 1995
56. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651, 1991
57. Huang TT, Carlson EJ, Epstein LB, Epstein CJ: The role of Superoxide anions in the establishment of an interferon-alpha-mediated antiviral state. Free Radic Res Commun 17:59, 1992
58. Pike MC, Fischer DG, Koren H, Snyderman R: Development of specific receptors for N-formylated chemotactic peptide in a human monocytic cell line stimulated with lymphokines. J Exp Med 152:31, 1980
59. Hass R, Hirano M, Kharbanda S, Rubin E, Meinhardt G, Kufe D: Resistance to phorbol ester-induced differentiation of a U-937 myeloid leukemia cell variant with a signaling defect upstream to Raf-1 kinase. Cell Growth Differ 4:657, 1993
60. Hass R, Meinhardt G. Hadam M, Bartels H: Characterization of human TUR leukemia cells: Continued cell cycle progression in the presence of phorbol ester is associated with resistance to apoptosis. Eur J Cell Biol 65:408, 1994
61. Hanson KD, Shichiri M, Follansbee MR, Sedivy JM: Effects of c-myc expression on cell cycle progression. Mol Cell Biol 14:5748, 1994
62. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9:3397, 1994
63. Kimura T, Kameoka M, Ikuta K: Amplification of Superoxide anion generation in phagocytic cells by HIV-1 infection. FEBS Lett 326:232, 1993
64. Huang TT, Carlson EJ, Epstein LB, Epstein CJ: The role of Superoxide anions in the establishment of an interferon-alpha-mediated antiviral state. Free Radic Res Commun 17:59, 1992